EN CH
x
x
Search
Ginkgo Health
Our Research On Ginkgo Biloba Jingelai ®️ Ginkgolide Injection Ginkgolide Dropping Pills CDMO Service International Standard Production Base
Ginkgolide Dropping Pills

Ginkgolide Dropping Pills belong to the category of National Traditional Chinese Medicine Class 1.2 new drugs in the Drug Registration Management Measures. It is a sequential therapy oral preparation developed on the basis of the already marketed Ginkgolide Injection.

  • Ingredient advantages

    Ginkgolide Dropping Pills and Ginkgolide Injection (National Medical Products Approval No. Z20110035, Jinggelai) ®) The main components are the same, all of which are high-purity ginkgolides, including bilobalide, ginkgolide A, ginkgolide B, ginkgolide C, and ginkgolide J. The total content of terpenoid lactones is over 95%.

  • Formulation advantages

    Unique drop pill formulation, easy to take, high bioavailability, and rapid onset of action.

Research progress

The Phase III clinical trial of Ginkgolide Dropping Pills has ended, with a production application submitted in April 2025. Production approval and the new drug certificate are expected to be obtained in 2026. After the product is launched, it is expected to bring a new oral treatment option for ischemic stroke patients with full course applicability and multiple benefits.

Guestbook
Guestbook
Top
Top